tiprankstipranks
Advertisement
Advertisement
Amneal Pharmaceuticals: Portfolio Shift to High-Margin Brands and Biosimilars Supports Buy Rating and Upside to $17 Target
PremiumRatingsAmneal Pharmaceuticals: Portfolio Shift to High-Margin Brands and Biosimilars Supports Buy Rating and Upside to $17 Target
2M ago
Amneal Posts Strong Q4 Results and Raises 2026 Outlook
Premium
Company Announcements
Amneal Posts Strong Q4 Results and Raises 2026 Outlook
2M ago
Options Volatility and Implied Earnings Moves Today, February 27, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, February 27, 2026
2M ago
Amneal Pharmaceuticals added to S&P SmallCap 600 Index
PremiumThe FlyAmneal Pharmaceuticals added to S&P SmallCap 600 Index
3M ago
Amneal Finalizes Nationwide Opioid Settlement Implementation Plan
Premium
Company Announcements
Amneal Finalizes Nationwide Opioid Settlement Implementation Plan
3M ago
Closing Bell Movers: Texas Instruments up 8%, F5 up 11% on earnings
Premium
The Fly
Closing Bell Movers: Texas Instruments up 8%, F5 up 11% on earnings
3M ago
Amneal Pharmaceuticals announces FDA approval for Boncresa, Oziltus BLAs
PremiumThe FlyAmneal Pharmaceuticals announces FDA approval for Boncresa, Oziltus BLAs
4M ago
Amneal Pharmaceuticals announces FDA approval for epinephrine injection vials
Premium
The Fly
Amneal Pharmaceuticals announces FDA approval for epinephrine injection vials
4M ago
Amneal Pharmaceuticals initiated with an Overweight at Barclays
Premium
The Fly
Amneal Pharmaceuticals initiated with an Overweight at Barclays
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100